Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure
- PMID: 25940075
- PMCID: PMC4795804
- DOI: 10.1016/j.healun.2015.03.017
Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure
Abstract
Background: Multivariable risk scores and exercise measures are well-validated risk prediction methods. Combining information from a functional evaluation and a risk model may improve accuracy of risk predictions. We analyzed whether adding exercise measures to the Seattle Heart Failure Model (SHFM) improves risk prediction accuracy in systolic heart failure.
Methods: We used a sample of patients from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) study (http://www.clinicaltrials.gov; unique identifier: NCT00047437) to examine the addition of peak oxygen consumption, expired volume per unit time/volume of carbon dioxide slope, 6-minute walk distance, or cardiopulmonary exercise duration to the SHFM. Multivariable Cox proportional hazards models were used to test the association between the combined end point (death, left ventricular assist device, or cardiac transplantation) and the addition of exercise variables to the SHFM.
Results: The sample included 2,152 patients. The SHFM and all exercise measures were associated with events (all p < 0.0001) in proportional hazards models. There was statistically significant improvement in risk estimation when exercise measures were added to the SHFM. However, the improvement in the C index for the addition of peak volume of oxygen consumption (+0.01), expired volume per unit time/volume of carbon dioxide slope (+0.02), 6-minute walk distance (-0.001), and cardiopulmonary exercise duration (+0.001) to the SHFM was small or slightly worse than the SHFM alone. Changes in risk assignment with the addition of exercise variables were minimal for patients above or below a 15% 1-year mortality.
Conclusions: Exercise performance measures and the SHFM are independently useful for predicting risk in systolic heart failure. Adding cardiopulmonary exercise testing measures and 6MWD to the SHFM offers only minimal improvement in risk reassignment at clinically meaningful cut points.
Keywords: Seattle Heart Failure Model; exercise; heart failure; risk factors; risk prediction.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Figures


References
-
- Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2006;25(9):1024–42. doi: 10.1016/j.healun.2006.06.008. - DOI - PubMed
-
- Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA: the journal of the American Medical Association. 1993;270(14):1702–7. - PubMed
-
- Forman DE, Fleg JL, Kitzman DW, Brawner CA, Swank AM, McKelvie RS, Clare RM, Ellis SJ, Dunlap ME, Bittner V. 6-Min Walk Test Provides Prognostic Utility Comparable to Cardiopulmonary Exercise Testing in Ambulatory Outpatients with Systolic Heart Failure. Journal of the American College of Cardiology. 2012;60(25):2653–61. doi: 10.1016/j.jacc.2012.08.1010. - DOI - PMC - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- U01 HL066491/HL/NHLBI NIH HHS/United States
- 5U01-HL-063747/HL/NHLBI NIH HHS/United States
- U01 HL064257/HL/NHLBI NIH HHS/United States
- R01 NR011873/NR/NINR NIH HHS/United States
- 5U01-HL-066491/HL/NHLBI NIH HHS/United States
- 5U01-HL-068973/HL/NHLBI NIH HHS/United States
- U01 HL066482/HL/NHLBI NIH HHS/United States
- U01 HL064250/HL/NHLBI NIH HHS/United States
- 5R01-NR-011873/NR/NINR NIH HHS/United States
- 5U01-HL-066482/HL/NHLBI NIH HHS/United States
- R37 AG018915/AG/NIA NIH HHS/United States
- R37-AG-018915/AG/NIA NIH HHS/United States
- P60-AG-010484/AG/NIA NIH HHS/United States
- U01 HL064265/HL/NHLBI NIH HHS/United States
- U01 HL066494/HL/NHLBI NIH HHS/United States
- 5U01-HL-064250/HL/NHLBI NIH HHS/United States
- U01 HL066497/HL/NHLBI NIH HHS/United States
- 5U01-HL-066497/HL/NHLBI NIH HHS/United States
- U01 HL066461/HL/NHLBI NIH HHS/United States
- U01 HL068973/HL/NHLBI NIH HHS/United States
- 5U01-HL-068980/HL/NHLBI NIH HHS/United States
- U01 HL064264/HL/NHLBI NIH HHS/United States
- U01 HL063747/HL/NHLBI NIH HHS/United States
- U01 HL066501/HL/NHLBI NIH HHS/United States
- 5U01-HL-066461/HL/NHLBI NIH HHS/United States
- 5U01-HL-064265/HL/NHLBI NIH HHS/United States
- 5U01-HL-066501/HL/NHLBI NIH HHS/United States
- 5U01-HL-066494/HL/NHLBI NIH HHS/United States
- U01 HL068980/HL/NHLBI NIH HHS/United States
- 5U01-HL-064264/HL/NHLBI NIH HHS/United States
- 5U01-HL-064257/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources